Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 102, Issue 4, Pages 588-590Publisher
WILEY
DOI: 10.1002/cpt.747
Keywords
-
Categories
Ask authors/readers for more resources
The development of new therapies for inflammatory bowel disease is plagued by high costs, potential side effects, and variable levels of effectiveness. Fecal microbial transplant in inflammatory bowel diseases can offer an alternative to traditionally developed pharmacologic therapies and has demonstrated the ability to induce disease remission in randomized control trials. However, questions remain about the ultimate role of this therapy in disease management, including long term safety, and the optimal composition of transplanted stool.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available